- Funding Opportunities
- Research Areas
- Dynamic Brain Circuits and Connections in Health and Disease
- Core facilities
- Research administration services
- DMCBH Membership
- News & Events
- Brain Matters Newsletter
- Neuroscience Research Colloquium
You are hereNewsroom
More oversight needed for consumer brain stimulation devices
As smart watches and fitness trackers explode in popularity, so is a new type of health and wellness tech marketed as being able to monitor and manipulate brain functions. Direct-to-consumer “neurotechnology” is a rapidly growing industry, predicted to top $3 billion by 2020.
However, many neurotechnology products are not regulated as medical devices, which UBC professor of neuroethics Dr. Peter Reiner believes is cause for concern. He and co-author Anna Wexler of the University of Pennsylvania outlined their concerns in an essay published recently in the journal Science.
In a Q&A with UBC Media Affairs, Dr. Reiner explains why there is a need for more oversight of neurotechnologies.
- More oversight needed for consumer brain stimulation devices (UBC Media Affairs, January 24, 2019)
- Oversight of direct-to-consumer neurotechnologies (Science; January 18, 2019)